Literature DB >> 9815722

IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma.

B Seliger1, S Hammers, A Höhne, R Zeidler, A Knuth, C D Gerharz, C Huber.   

Abstract

Some human tumor cells exhibit deficient expression of the peptide transporters TAP1 and TAP2 and of the proteasome subunits low molecular weight protein (LMP)-2 and LMP-7, which could be partially restored by cytokine treatment. Here, we show that IFN-gamma stimulation of human renal cell carcinoma lines increased the MHC class I, transporter associated with antigen processing (TAP), and LMP transcript and protein levels, but TAP and LMP expression are more rapidly induced by IFN-gamma than MHC class I molecules. No correlation between the level of induction of the MHC class I antigen presentation genes and IFN sensitivity/resistance was detected. The IFN-gamma-mediated increase of MHC class I, TAP-1, and LMP-2 expression was independent of de novo protein synthesis. Analysis of the dual TAP-1/LMP-2 promoter activity revealed that TAP-1 and LMP-2 expression are controlled by IFN-gamma at the transcriptional level. Site-specific mutations in the IFN-gamma-responsive element of the TAP-1/LMP-2 promoter blocked induction by IFN-gamma. Thus, the IFN-gamma-mediated coordinated transcriptional up-regulation of TAP-1 and LMP-2 expression occurs through the use of a common regulatory element, which might result in enhanced recognition of renal cell carcinoma cells by the immune system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9815722

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  14 in total

Review 1.  Dysfunction of antigen processing and presentation by dendritic cells in cancer.

Authors:  Joanna Bandola-Simon; Paul A Roche
Journal:  Mol Immunol       Date:  2018-04-05       Impact factor: 4.407

2.  Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity.

Authors:  Kerstin Herzer; Christine S Falk; Jens Encke; Sören T Eichhorst; Axel Ulsenheimer; Barbara Seliger; Peter H Krammer
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.

Authors:  Akhil Chawla; Gheath Alatrash; Anne V Philips; Na Qiao; Pariya Sukhumalchandra; Celine Kerros; Iulia Diaconu; Victor Gall; Samantha Neal; Haley L Peters; Karen Clise-Dwyer; Jeffrey J Molldrem; Elizabeth A Mittendorf
Journal:  Cancer Immunol Immunother       Date:  2016-04-29       Impact factor: 6.968

4.  Differential contribution of TAP and tapasin to HLA class I antigen expression.

Authors:  Alan Belicha-Villanueva; Sarah McEvoy; Kelly Cycon; Soldano Ferrone; Sandra O Gollnick; Naveen Bangia
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

Review 5.  Viral dedication to vigorous destruction of interferon receptors.

Authors:  Chuan Xia; Paul Anderson; Bumsuk Hahm
Journal:  Virology       Date:  2018-07-06       Impact factor: 3.616

6.  Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.

Authors:  Chuan Xia; Jennifer J Wolf; Madhuvanthi Vijayan; Caleb J Studstill; Wenjun Ma; Bumsuk Hahm
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

7.  ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer.

Authors:  Jiehui Deng; Aatish Thennavan; Igor Dolgalev; Ting Chen; Jie Li; Antonio Marzio; John T Poirier; David H Peng; Mirna Bulatovic; Subhadip Mukhopadhyay; Heather Silver; Eleni Papadopoulos; Val Pyon; Cassandra Thakurdin; Han Han; Fei Li; Shuai Li; Hailin Ding; Hai Hu; Yuanwang Pan; Vajira Weerasekara; Baishan Jiang; Eric S Wang; Ian Ahearn; Mark Philips; Thales Papagiannakopoulos; Aristotelis Tsirigos; Eli Rothenberg; Justin Gainor; Gordon J Freeman; Charles M Rudin; Nathanael S Gray; Peter S Hammerman; Michele Pagano; John V Heymach; Charles M Perou; Nabeel Bardeesy; Kwok-Kin Wong
Journal:  Nat Cancer       Date:  2021-05-17

8.  Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.

Authors:  Barbara Seliger; Diana Handke; Elisabeth Schabel; Juergen Bukur; Rudolf Lichtenfels; Reinhard Dammann
Journal:  J Transl Med       Date:  2009-10-26       Impact factor: 5.531

Review 9.  The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Authors:  Tobias Bald; Matthew F Krummel; Mark J Smyth; Kevin C Barry
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

10.  Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model.

Authors:  Chunrui Tan; Varun Reddy; Jens Dannull; Enyu Ding; Smita K Nair; Douglas S Tyler; Scott K Pruitt; Walter T Lee
Journal:  J Transl Med       Date:  2013-06-17       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.